Clinical trials recruiting for Non-Melanoma Skin Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| EBNK-001 + IL-15 + Pembrolizumab | 1 |
| Nicotinamide | 1 |
| Radiotherapy (RT) | 1 |
| Water-filtered infrared-A-hyperthermia (wIRA) hyperthermia combined | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Ohio | 2 |
Top cities
Self-screener
Recruiting trials
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
- Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
- Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
- Skin Cancer and Hyperthermia and Radiotherapy
- The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
Related conditions
Trials recruiting for Non-Melanoma Skin Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Non-Melanoma Skin Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.